LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $344,840 | -16.7% | 5,755 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $414,187 | -1.9% | 5,755 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $422,359 | +10.1% | 5,755 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $383,743 | -22.6% | 5,755 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $496,000 | -3.1% | 5,755 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $512,000 | -71.3% | 5,755 | -63.8% | 0.01% | -66.7% |
| Q1 2022 | $1,786,000 | -29.4% | 15,914 | -1.8% | 0.02% | -25.0% |
| Q4 2021 | $2,531,000 | +2.1% | 16,205 | -9.0% | 0.03% | 0.0% |
| Q3 2021 | $2,479,000 | +6.2% | 17,808 | 0.0% | 0.03% | +16.7% |
| Q2 2021 | $2,334,000 | -14.0% | 17,808 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $2,713,000 | -7.5% | 17,808 | -39.6% | 0.03% | -10.0% |
| Q4 2020 | $2,934,000 | – | 29,504 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |